These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 33026316)

  • 1. Population pharmacokinetics of ciprofloxacin in Pakistani patients suffering from enteric fever.
    Saleem R; Khan HM; Usman M; Khokhar MI; Rasheed H; Abbas M; Khan RR; Zaman M; Maqsood Z
    Int J Clin Pharmacol Ther; 2021 Jan; 59(1):47-54. PubMed ID: 33026316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of meropenem among post-operative patients in Pakistan.
    Zaman M; Khan HM; Usman M; Khokhar MI; Rasheed H; Abbas M; Khan RR; Saleem R
    Int J Clin Pharmacol Ther; 2021 May; 59(5):398-408. PubMed ID: 33480841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan.
    Munir MM; Rasheed H; Khokhar MI; Khan RR; Saeed HA; Abbas M; Ali M; Bilal R; Nawaz HA; Khan AM; Qamar S; Anjum SM; Usman M
    Front Pharmacol; 2021; 12():721819. PubMed ID: 34858169
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative pharmacokinetics of valproic acid among Pakistani and South Korean patients: A population pharmacokinetic study.
    Usman M; Shaukat QU; Khokhar MI; Bilal R; Khan RR; Saeed HA; Ali M; Khan HM
    PLoS One; 2022; 17(8):e0272622. PubMed ID: 36001534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of levetiracetam in neonates with seizures.
    Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
    J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
    Tsuji Y; Yukawa E; Hiraki Y; Matsumoto K; Mizoguchi A; Morita K; Kamimura H; Karube Y; To H
    J Clin Pharmacol; 2013 Sep; 53(9):967-73. PubMed ID: 23918457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic analysis of meropenem in Japanese adult patients.
    Muro T; Sasaki T; Hosaka N; Umeda Y; Takemoto S; Yamamoto H; Kamimura H; Higuchi S; Karube Y
    J Clin Pharm Ther; 2011 Apr; 36(2):230-6. PubMed ID: 21366653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
    ElDesoky ES; Kumar V; Alorainy MS; Hamdi MM; Derendorf H
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):617-26. PubMed ID: 19049695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
    Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
    Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.